Top line data on the ATTRACT study
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients
Idiopathic Pulmonary Fibrosis: 5 Things to Know
C21 shows promise against COVID-19 where other drugs have failed
Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic